These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 9303925)

  • 1. NO therapy?
    Schechter AN
    J Clin Invest; 1997 Sep; 100(5):955-6. PubMed ID: 9303925
    [No Abstract]   [Full Text] [Related]  

  • 2. Can we just say NO to sickle cell anemia?
    Nagel RL
    J Clin Invest; 1999 Oct; 104(7):847-8. PubMed ID: 10510323
    [No Abstract]   [Full Text] [Related]  

  • 3. Arginine metabolism and nitric oxide bioavailability in sickle cell disease.
    Jain S; Gladwin MT
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):e247-8. PubMed ID: 20724948
    [No Abstract]   [Full Text] [Related]  

  • 4. Nitric oxide-based therapies in sickle cell disease: the evidence continues to mount.
    Machado RF
    Crit Care Med; 2007 Feb; 35(2):654-5. PubMed ID: 17251718
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitric oxide production from hydroxyurea.
    King SB
    Free Radic Biol Med; 2004 Sep; 37(6):737-44. PubMed ID: 15304249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood feud: keeping hemoglobin from nixing NO.
    Liao JC
    Nat Med; 2002 Dec; 8(12):1350-1. PubMed ID: 12457171
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials in sickle cell disease: adopting the combination chemotherapy paradigm.
    Steinberg MH
    Am J Hematol; 2008 Jan; 83(1):1-3. PubMed ID: 17724701
    [No Abstract]   [Full Text] [Related]  

  • 8. Nitric oxide metabolism and the acute chest syndrome of sickle cell anemia.
    Sullivan KJ; Kissoon N; Gauger C
    Pediatr Crit Care Med; 2008 Mar; 9(2):159-68. PubMed ID: 18477929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidant-mediated impairment of nitric oxide signaling in sickle cell disease--mechanisms and consequences.
    Aslan M; Freeman BA
    Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):95-105. PubMed ID: 15040433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased adhesive properties of neutrophils in sickle cell disease may be reversed by pharmacological nitric oxide donation.
    Canalli AA; Franco-Penteado CF; Saad ST; Conran N; Costa FF
    Haematologica; 2008 Apr; 93(4):605-9. PubMed ID: 18326523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell disease: role of reactive oxygen and nitrogen metabolites.
    Wood KC; Granger DN
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):926-32. PubMed ID: 17645642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in sickle cell disease].
    de Montalembert M
    Bull Acad Natl Med; 2008 Oct; 192(7):1375-81; discussion 1381. PubMed ID: 19445363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin and nitric oxide.
    Pawloski JR
    N Engl J Med; 2003 Jul; 349(4):402-5; author reply 402-5. PubMed ID: 12879895
    [No Abstract]   [Full Text] [Related]  

  • 14. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
    Morris CR; Morris SM; Hagar W; Van Warmerdam J; Claster S; Kepka-Lenhart D; Machado L; Kuypers FA; Vichinsky EP
    Am J Respir Crit Care Med; 2003 Jul; 168(1):63-9. PubMed ID: 12626350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical trials of new therapeutic pharmacology for sickle cell disease].
    Brugnara C; de Franceschi L
    Sante; 2006; 16(4):263-8. PubMed ID: 17446160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red cell survival and NO scavenging in sickle cell disease.
    Bunn HF
    Am J Hematol; 2016 Dec; 91(12):1173-1174. PubMed ID: 27718525
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased exhaled nitric oxide in sickle cell disease: relationship with chronic lung involvement.
    Girgis RE; Qureshi MA; Abrams J; Swerdlow P
    Am J Hematol; 2003 Mar; 72(3):177-84. PubMed ID: 12605389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologic, pathologic and therapeutic implications for hemoglobin interactions with nitric oxide.
    Patel RP; Gladwin MT
    Free Radic Biol Med; 2004 Feb; 36(4):399-401. PubMed ID: 14975442
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of acute pain crisis on exhaled nitric oxide levels in children with sickle cell disease.
    Pawar SS; Panepinto JA; Brousseau DC
    Pediatr Blood Cancer; 2008 Jan; 50(1):111-3. PubMed ID: 16619223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin.
    Doherty DH; Doyle MP; Curry SR; Vali RJ; Fattor TJ; Olson JS; Lemon DD
    Nat Biotechnol; 1998 Jul; 16(7):672-6. PubMed ID: 9661203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.